{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:25:23Z","timestamp":1787538323608,"version":"build-2736575974"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16254-1","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:13:16Z","timestamp":1780481596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the expression of CTLA-4 and CD28 genes as immune regulators in patients with colorectal polyps"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6477-770X","authenticated-orcid":false,"given":"Marziyeh","family":"Etesami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2747-3479","authenticated-orcid":false,"given":"Flora","family":"Forouzesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-3131","authenticated-orcid":false,"given":"Amirreza","family":"Hooshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5167-2569","authenticated-orcid":false,"given":"Mahsa Saeedi","family":"Niasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardis Ketabi","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-004X","authenticated-orcid":false,"given":"Ehsan","family":"Nazemalhosseini-Mojarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"9","key":"16254_CR1","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/jcp.31076","volume":"238","author":"MKA El-Aziz","year":"2023","unstructured":"El-Aziz MKA, Dawoud A, Kiriacos CJ, Fahmy SA, Hamdy NM, Youness RA. Decoding hepatocarcinogenesis from a noncoding RNAs perspective. J Cell Physiol. 2023;238(9):1982\u20132009.","journal-title":"J Cell Physiol"},{"issue":"7","key":"16254_CR2","first-page":"3121","volume":"11","author":"A Saini","year":"2020","unstructured":"Saini A, Kumar M, Bhatt S, Saini V, Malik A. Cancer causes and treatments. Int J Pharm Sci Res. 2020;11(7):3121\u201334.","journal-title":"Int J Pharm Sci Res"},{"issue":"5","key":"16254_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","volume":"54","author":"H Easwaran","year":"2014","unstructured":"Easwaran H, Tsai H-C, Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell. 2014;54(5):716\u201327.","journal-title":"Mol Cell"},{"issue":"4","key":"16254_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"4","key":"16254_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncb2717","volume":"15","author":"JP Medema","year":"2013","unstructured":"Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013;15(4):338\u201344.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"16254_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","volume":"11","author":"D Nassar","year":"2016","unstructured":"Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11(1):47\u201376.","journal-title":"Annu Rev Pathol"},{"issue":"14","key":"16254_CR7","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.3390\/cancers13143382","volume":"13","author":"BC Tse","year":"2021","unstructured":"Tse BC, Welham Z, Engel AF, Molloy MP. Genomic, microbial and immunological microenvironment of colorectal polyps. Cancers. 2021;13(14):3382.","journal-title":"Cancers"},{"key":"16254_CR8","doi-asserted-by":"publisher","first-page":"122850","DOI":"10.1016\/j.lfs.2024.122850","volume":"352","author":"NI Rizk","year":"2024","unstructured":"Rizk NI, Kassem DH, Abulsoud AI, AbdelHalim S, Yasser MB, Kamal MM, et al. Revealing the role of serum exosomal novel long non-coding RNA NAMPT-AS as a promising diagnostic\/prognostic biomarker in colorectal cancer patients. Life Sci. 2024;352:122850.","journal-title":"Life Sci"},{"key":"16254_CR9","doi-asserted-by":"publisher","first-page":"122946","DOI":"10.1016\/j.lfs.2024.122946","volume":"354","author":"NM Hamdy","year":"2024","unstructured":"Hamdy NM, Zaki MB, Rizk NI, Abdelmaksoud NM, Abd-Elmawla MA, Ismail RA, et al. Unraveling the ncRNA landscape that governs colorectal cancer: a roadmap to personalized therapeutics. Life Sci. 2024;354:122946.","journal-title":"Life Sci"},{"issue":"7","key":"16254_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cgh.2012.12.004","volume":"11","author":"S Sweetser","year":"2013","unstructured":"Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol. 2013;11(7):760\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"16254_CR11","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1053\/j.gastro.2021.01.214","volume":"160","author":"A Duvvuri","year":"2021","unstructured":"Duvvuri A, Chandrasekar VT, Srinivasan S, Narimiti A, Dasari C, Nutalapati V, et al. Risk of colorectal cancer and cancer related mortality after detection of low-risk or high-risk adenomas, compared with no adenoma, at index colonoscopy: a systematic review and meta-analysis. Gastroenterology. 2021;160(6):1986\u201396. e3.","journal-title":"Gastroenterology"},{"issue":"6","key":"16254_CR12","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.gie.2021.02.008","volume":"93","author":"D Kedrin","year":"2021","unstructured":"Kedrin D, Butterly LF, Anderson JC. Risk for individuals with index small (<\u20091\u00a0cm) hyperplastic polyps. Gastrointest Endosc. 2021;93(6):1408\u201310.","journal-title":"Gastrointest Endosc"},{"key":"16254_CR13","doi-asserted-by":"crossref","unstructured":"Cao D, Xu H, Xu X, Guo T, Ge W. High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients. Oncoimmunology. 2019;8(9):e1629258.","DOI":"10.1080\/2162402X.2019.1629258"},{"key":"16254_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2020.00369","volume":"11","author":"E Picard","year":"2020","unstructured":"Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol. 2020;11:369.","journal-title":"Front Immunol"},{"issue":"2","key":"16254_CR15","first-page":"208","volume":"6","author":"JL Markman","year":"2015","unstructured":"Markman JL, Shiao SL. Impact of the immune system and immunotherapy in colorectal cancer. J Gastrointest Oncol. 2015;6(2):208.","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"16254_CR16","doi-asserted-by":"publisher","first-page":"e952197","DOI":"10.4161\/21624011.2014.952197","volume":"3","author":"G Sconocchia","year":"2014","unstructured":"Sconocchia G, Eppenberger S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, et al. NK cells and T cells cooperate during the clinical course of colorectal cancer. Oncoimmunology. 2014;3(8):e952197.","journal-title":"Oncoimmunology"},{"issue":"1","key":"16254_CR17","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1038\/s41467-022-34467-3","volume":"13","author":"S Tiberti","year":"2022","unstructured":"Tiberti S, Catozzi C, Croci O, Ballerini M, Cagnina D, Soriani C, et al. GZMKhigh CD8\u2009+\u2009T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome. Nat Commun. 2022;13(1):6752.","journal-title":"Nat Commun"},{"key":"16254_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-1","volume":"10","author":"J Galon","year":"2012","unstructured":"Galon J, Pag\u00e8s F, Marincola FM, Angell HK, Thurin M, Lugli A, et al. Cancer classification using the Immunoscore: a worldwide task force. J translational Med. 2012;10:1\u201310.","journal-title":"J translational Med"},{"issue":"1","key":"16254_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","volume":"39","author":"J Galon","year":"2013","unstructured":"Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity. 2013;39(1):11\u201326.","journal-title":"Immunity"},{"key":"16254_CR20","unstructured":"Morgand E. Characterization of the immune microenvironment in colorectal precancerous lesions [thesis]. Sorbonne Universit\u00e9; 2022."},{"issue":"7766","key":"16254_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-019-1330-0","volume":"571","author":"C Mascaux","year":"2019","unstructured":"Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, et al. Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature. 2019;571(7766):570\u20135.","journal-title":"Nature"},{"issue":"18","key":"16254_CR22","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2217\/fon-2017-0145","volume":"13","author":"M Koi","year":"2017","unstructured":"Koi M, Carethers JM. The colorectal cancer immune microenvironment and approach to immunotherapies. Future Oncol. 2017;13(18):1633\u201347.","journal-title":"Future Oncol"},{"issue":"1","key":"16254_CR23","doi-asserted-by":"publisher","first-page":"1790125","DOI":"10.1080\/2162402X.2020.1790125","volume":"9","author":"G Trimaglio","year":"2020","unstructured":"Trimaglio G, Tilkin-Mariam\u00e9 A-F, Feliu V, Lauz\u00e9ral-Vizcaino F, Tosolini M, Valle C, et al. Colon-specific immune microenvironment regulates cancer progression versus rejection. Oncoimmunology. 2020;9(1):1790125.","journal-title":"Oncoimmunology"},{"issue":"7","key":"16254_CR24","doi-asserted-by":"publisher","first-page":"e0159373","DOI":"10.1371\/journal.pone.0159373","volume":"11","author":"A Maglietta","year":"2016","unstructured":"Maglietta A, Maglietta R, Staiano T, Bertoni R, Ancona N, Marra G, et al. The immune landscapes of polypoid and nonpolypoid precancerous colorectal lesions. PLoS ONE. 2016;11(7):e0159373.","journal-title":"PLoS ONE"},{"issue":"9","key":"16254_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/biomedicines9091075","volume":"9","author":"S Makaremi","year":"2021","unstructured":"Makaremi S, Asadzadeh Z, Hemmat N, Baghbanzadeh A, Sgambato A, Ghorbaninezhad F, et al. Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects. Biomedicines. 2021;9(9):1075.","journal-title":"Biomedicines"},{"key":"16254_CR26","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang X-L, Liu J-J, Qian Z-Y, Pan Z-Y, Song N-P, et al. ICOS\/ICOSLG and PD-1 Co-expression is associated with the progression of colorectal precancerous-carcinoma immune microenvironment. J Inflamm Res. 2023;16:977\u201392.","DOI":"10.2147\/JIR.S401123"},{"issue":"6029","key":"16254_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","volume":"332","author":"OS Qureshi","year":"2011","unstructured":"Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332(6029):600\u20133.","journal-title":"Science"},{"issue":"12","key":"16254_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nri1248","volume":"3","author":"O Acuto","year":"2003","unstructured":"Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol. 2003;3(12):939\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"16254_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 costimulation: from mechanism to therapy. Immunity. 2016;44(5):973\u201388.","journal-title":"Immunity"},{"issue":"10","key":"16254_CR30","first-page":"5391","volume":"35","author":"O Kucukhuseyin","year":"2015","unstructured":"Kucukhuseyin O, Turan S, Yanar K, Arikan S, Duzkoylu Y, Aydin S, et al. Individual and combined effects of CTLA4-CD28 variants and oxidant-antioxidant status on the development of colorectal cancer. Anticancer Res. 2015;35(10):5391\u2013400.","journal-title":"Anticancer Res"},{"issue":"2A","key":"16254_CR31","first-page":"779","volume":"28","author":"I Gruber","year":"2008","unstructured":"Gruber I, El Yousfi S, D\u00fcrr-St\u00f6rzer S, Wallwiener D, Solomayer E, Fehm T. Down-regulation of CD28, TCR-zeta (\u03b6) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients. Anticancer Res. 2008;28(2A):779\u201384.","journal-title":"Anticancer Res"},{"key":"16254_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07412-0","volume":"20","author":"D Sun","year":"2020","unstructured":"Sun D, Tian L, Bian T, Zhao H, Tao J, Feng L, et al. The role of CD28 in the prognosis of young lung adenocarcinoma patients. BMC Cancer. 2020;20:1\u201311.","journal-title":"BMC Cancer"},{"issue":"2","key":"16254_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/diagnostics12020251","volume":"12","author":"J \u015awiderska","year":"2022","unstructured":"\u015awiderska J, Koz\u0142owski M, Gaur M, Pius-Sadowska E, Kwiatkowski S, Machali\u0144ski B, et al. Clinical significance of BTLA, CD27, CD70, CD28 and CD80 as diagnostic and prognostic markers in ovarian cancer. Diagnostics. 2022;12(2):251.","journal-title":"Diagnostics"},{"key":"16254_CR34","doi-asserted-by":"crossref","unstructured":"Azuma M, Yagita H. Co-signal molecules in T cell activation: immune regulation in health and disease. Springer Nature; 2019.","DOI":"10.1007\/978-981-32-9717-3"},{"issue":"6","key":"16254_CR35","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00705-021-04981-8","volume":"166","author":"NA Ali","year":"2021","unstructured":"Ali NA, Hamdy NM, Gibriel AA, El Mesallamy HO. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma. Arch Virol. 2021;166(6):1643\u201351.","journal-title":"Arch Virol"},{"key":"16254_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clinbiochem.2021.06.007","volume":"96","author":"AM Kamal","year":"2021","unstructured":"Kamal AM, Wasfey EF, Elghamry WR, Sabry OM, Elghobary HA, Radwan SM. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes. Clin Biochem. 2021;96:13\u20138.","journal-title":"Clin Biochem"},{"issue":"13","key":"16254_CR37","doi-asserted-by":"publisher","first-page":"9910","DOI":"10.1074\/jbc.M111.337154","volume":"287","author":"H Fayyad-Kazan","year":"2012","unstructured":"Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, et al. MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem. 2012;287(13):9910\u201322.","journal-title":"J Biol Chem"},{"key":"16254_CR38","doi-asserted-by":"publisher","first-page":"144888","DOI":"10.1016\/j.gene.2020.144888","volume":"754","author":"N Skafi","year":"2020","unstructured":"Skafi N, Fayyad-Kazan M, Badran B. Immunomodulatory role for MicroRNAs: regulation of PD-1\/PD-L1 and CTLA-4 immune checkpoints expression. Gene. 2020;754:144888.","journal-title":"Gene"},{"key":"16254_CR39","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fimmu.2018.01400","volume":"9","author":"N Teteloshvili","year":"2018","unstructured":"Teteloshvili N, Dekkema G, Boots AM, Heeringa P, Jellema P, De Jong D, et al. Involvement of MicroRNAs in the aging-related decline of CD28 expression by human T cells. Front Immunol. 2018;9:1400.","journal-title":"Front Immunol"},{"issue":"7483","key":"16254_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352.","journal-title":"Nature"},{"issue":"6147","key":"16254_CR41","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1240925","volume":"341","author":"S Carpenter","year":"2013","unstructured":"Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science. 2013;341(6147):789\u201392.","journal-title":"Science"},{"issue":"4","key":"16254_CR42","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ncrna.2023.07.002","volume":"8","author":"I Gareev","year":"2023","unstructured":"Gareev I, Ramirez MJE, Goncharov E, Ivliev D, Shumadalova A, Ilyasova T, et al. MiRNAs and lncRNAs in the regulation of innate immune signaling. Non-coding RNA Res. 2023;8(4):534\u201341.","journal-title":"Non-coding RNA Res"},{"issue":"6","key":"16254_CR43","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"4","key":"16254_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"21","key":"16254_CR45","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-10-1938","volume":"70","author":"L Hong","year":"2010","unstructured":"Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, et al. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 2010;70(21):8547\u201357.","journal-title":"Cancer Res"},{"issue":"2","key":"16254_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaci.2013.02.005","volume":"132","author":"D Zhu","year":"2013","unstructured":"Zhu D, Pan C, Li L, Bian Z, Lv Z, Shi L, et al. MicroRNA-17\/20a\/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein \u03b1. J allergy Clin Immunol. 2013;132(2):426\u201336. e8.","journal-title":"J allergy Clin Immunol"},{"issue":"29","key":"16254_CR47","doi-asserted-by":"publisher","first-page":"45199","DOI":"10.18632\/oncotarget.9900","volume":"7","author":"D Cheng","year":"2016","unstructured":"Cheng D, Zhao S, Tang H, Zhang D, Sun H, Yu F, et al. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Oncotarget. 2016;7(29):45199\u2013213.","journal-title":"Oncotarget"},{"issue":"1","key":"16254_CR48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ncomms2276","volume":"3","author":"Y Ma","year":"2012","unstructured":"Ma Y, Zhang P, Wang F, Zhang H, Yang Y, Shi C, et al. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun. 2012;3(1):1291.","journal-title":"Nat Commun"},{"issue":"21","key":"16254_CR49","doi-asserted-by":"publisher","first-page":"9688","DOI":"10.1093\/nar\/gkt680","volume":"41","author":"X Yang","year":"2013","unstructured":"Yang X, Du WW, Li H, Liu F, Khorshidi A, Rutnam ZJ, et al. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 2013;41(21):9688\u2013704.","journal-title":"Nucleic Acids Res"},{"key":"16254_CR50","doi-asserted-by":"publisher","first-page":"109745","DOI":"10.1016\/j.biopha.2019.109745","volume":"123","author":"Q Jiao","year":"2020","unstructured":"Jiao Q, Ren Y, Gabrie ANA, Wang Q, Wang Y, Du L, et al. Advances of immune checkpoints in colorectal cancer treatment. Biomed Pharmacother. 2020;123:109745.","journal-title":"Biomed Pharmacother"},{"key":"16254_CR51","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels J, Kasi PM, Wallace M. Pure-amc. Lancet. 2019;394:1467\u201380.","journal-title":"Lancet"},{"key":"16254_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-017-0283-9","volume":"5","author":"LM Janssen","year":"2017","unstructured":"Janssen LM, Ramsay EE, Logsdon CD, Overwijk WW. The immune system in cancer metastasis: friend or foe? J Immunother Cancer. 2017;5:1\u201314.","journal-title":"J Immunother Cancer"},{"key":"16254_CR53","doi-asserted-by":"crossref","unstructured":"Candeias M, Gaipl SS. U. The immune system in cancer prevention, development and therapy. Anti-cancer agents in Medicinal Chemistry. 2016;16(1):101\u20137.","DOI":"10.2174\/1871520615666150824153523"},{"issue":"3","key":"16254_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/biomedicines13030699","volume":"13","author":"U Silinskaite","year":"2025","unstructured":"Silinskaite U, Valciukiene J, Jakubauskas M, Poskus T. The immune environment in colorectal adenoma: a systematic review. Biomedicines. 2025;13(3):699.","journal-title":"Biomedicines"},{"issue":"4","key":"16254_CR55","first-page":"1351","volume":"6","author":"T Saito","year":"2000","unstructured":"Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL. Spontaneous apoptosis of CD8\u2009+\u2009T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res. 2000;6(4):1351\u201364.","journal-title":"Clin Cancer Res"},{"key":"16254_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF01517175","volume":"39","author":"TL Whiteside","year":"1994","unstructured":"Whiteside TL, Parmiani G. Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother. 1994;39:15\u201321.","journal-title":"Cancer Immunol Immunother"},{"issue":"18","key":"16254_CR57","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.3390\/cancers15184616","volume":"15","author":"R Paolini","year":"2023","unstructured":"Paolini R, Molfetta R. Dysregulation of DNAM-1-mediated NK cell anti-cancer responses in the tumor microenvironment. Cancers. 2023;15(18):4616.","journal-title":"Cancers"},{"issue":"4","key":"16254_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41422-020-0277-x","volume":"30","author":"A Schnell","year":"2020","unstructured":"Schnell A, Bod L, Madi A, Kuchroo VK. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity. Cell Res. 2020;30(4):285\u201399.","journal-title":"Cell Res"},{"key":"16254_CR59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.003","volume":"457","author":"R Saleh","year":"2019","unstructured":"Saleh R, Elkord E. Treg-mediated acquired resistance to immune checkpoint inhibitors. Cancer Lett. 2019;457:168\u201379.","journal-title":"Cancer Lett"},{"key":"16254_CR60","doi-asserted-by":"crossref","unstructured":"Saleh R, Elkord E, editors. Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression. Semin Cancer Biol. 2020;65:13\u201327.","DOI":"10.1016\/j.semcancer.2019.07.017"},{"issue":"29","key":"16254_CR61","doi-asserted-by":"publisher","first-page":"45199","DOI":"10.18632\/oncotarget.9900","volume":"7","author":"D Cheng","year":"2016","unstructured":"Cheng D, Zhao S, Tang H, Zhang D, Sun H, Yu F, et al. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Oncotarget. 2016;7(29):45199.","journal-title":"Oncotarget"},{"issue":"28","key":"16254_CR62","doi-asserted-by":"publisher","first-page":"45060","DOI":"10.18632\/oncotarget.15023","volume":"8","author":"H Li","year":"2017","unstructured":"Li H, Wu Q, Li T, Liu C, Xue L, Ding J, et al. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review. Oncotarget. 2017;8(28):45060.","journal-title":"Oncotarget"},{"issue":"12","key":"16254_CR63","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"Mogilyansky E, Rigoutsos I. The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013;20(12):1603\u201314.","journal-title":"Cell Death Differ"},{"issue":"6","key":"16254_CR64","first-page":"1624","volume":"40","author":"L-L Fang","year":"2017","unstructured":"Fang L-L, Wang X-H, Sun B-F, Zhang X-D, Zhu X-H, Yu Z-J, et al. Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells. Int J Mol Med. 2017;40(6):1624\u201330.","journal-title":"Int J Mol Med"},{"issue":"2","key":"16254_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/cbin.11714","volume":"46","author":"J Hu","year":"2022","unstructured":"Hu J, Huang L, Ding Q, Lv J, Chen Z. Long noncoding RNA HAGLR sponges miR-338\u20103p to promote 5\u2010Fu resistance in gastric cancer through targeting the LDHA\u2010glycolysis pathway. Cell Biol Int. 2022;46(2):173\u201384.","journal-title":"Cell Biol Int"},{"issue":"15","key":"16254_CR66","doi-asserted-by":"publisher","first-page":"19306","DOI":"10.18632\/aging.203272","volume":"13","author":"L Jin","year":"2021","unstructured":"Jin L, Luo C, Wu X, Li M, Wu S, Feng Y. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p. Aging. 2021;13(15):19306.","journal-title":"Aging"},{"issue":"6","key":"16254_CR67","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.21037\/tcr.2019.09.43","volume":"8","author":"L Rao","year":"2019","unstructured":"Rao L, Luo L, Luo L, Chen S, Ran R, Liu X. Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancer. Translational cancer Res. 2019;8(6):2264.","journal-title":"Translational cancer Res"},{"key":"16254_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01280-1","volume":"20","author":"L Meng","year":"2020","unstructured":"Meng L, Li Z, Chen Y, Liu D, Liu Z. LINC00689 promotes prostate cancer progression via regulating miR-496\/CTNNB1 to activate Wnt pathway. Cancer Cell Int. 2020;20:1\u201312.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"16254_CR69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s11658-022-00385-x","volume":"27","author":"R Li","year":"2022","unstructured":"Li R, Wang X, Zhu C, Wang K. lncRNA PVT1: a novel oncogene in multiple cancers. Cell Mol Biol Lett. 2022;27(1):84.","journal-title":"Cell Mol Biol Lett"},{"key":"16254_CR70","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fonc.2019.00609","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang W, Zhou R, Wu Y, Liu Y, Su W, Xiong W, et al. PVT1 promotes cancer progression via MicroRNAs. Front Oncol. 2019;9:609.","journal-title":"Front Oncol"},{"key":"16254_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1091-2","volume":"18","author":"S Qin","year":"2019","unstructured":"Qin S, Xu L, Yi M, Yu S, Wu K, Luo S. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Mol Cancer. 2019;18:1\u201314.","journal-title":"Mol Cancer"},{"issue":"1","key":"16254_CR72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol. 2016;39(1):98\u2013106.","journal-title":"Am J Clin Oncol"},{"key":"16254_CR73","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.biopha.2018.07.098","volume":"106","author":"E Chen","year":"2018","unstructured":"Chen E, Li Q, Wang H, Yang F, Min L, Yang J. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study. Biomed Pharmacother. 2018;106:1370\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"36","key":"16254_CR74","doi-asserted-by":"publisher","first-page":"24209","DOI":"10.18632\/oncotarget.24819","volume":"9","author":"VY Shin","year":"2018","unstructured":"Shin VY, Siu M-T, Liu X, Ng EK, Kwong A, Chu K-M. MiR-92 suppresses proliferation and induces apoptosis by targeting EP4\/Notch1 axis in gastric cancer. Oncotarget. 2018;9(36):24209.","journal-title":"Oncotarget"},{"issue":"10","key":"16254_CR75","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.celrep.2017.08.041","volume":"20","author":"XL Li","year":"2017","unstructured":"Li XL, Subramanian M, Jones MF, Chaudhary R, Singh DK, Zong X, et al. Long noncoding RNA PURPL suppresses basal p53 levels and promotes tumorigenicity in colorectal cancer. Cell Rep. 2017;20(10):2408\u201323.","journal-title":"Cell Rep"},{"key":"16254_CR76","doi-asserted-by":"crossref","unstructured":"Hao H, Chen H, Xie L, Liu H, Wang D. LncRNA KCNQ1OT1 promotes proliferation, invasion and metastasis of prostate cancer by regulating miR-211-5p\/CHI3L1 pathway. OncoTargets Therapy. 2021;14:1659\u201371.","DOI":"10.2147\/OTT.S288785"},{"issue":"11","key":"16254_CR77","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/biom11111602","volume":"11","author":"P Cagle","year":"2021","unstructured":"Cagle P, Qi Q, Niture S, Kumar D. KCNQ1OT1: an oncogenic long noncoding RNA. Biomolecules. 2021;11(11):1602.","journal-title":"Biomolecules"},{"issue":"1","key":"16254_CR78","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s10020-022-00521-5","volume":"28","author":"S-L He","year":"2022","unstructured":"He S-L, Chen Y-L, Chen Q-H, Tian Q, Yi S-J. LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter. Mol Med. 2022;28(1):112.","journal-title":"Mol Med"},{"key":"16254_CR79","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00262-020-02645-1","volume":"69","author":"Y Omura","year":"2020","unstructured":"Omura Y, Toiyama Y, Okugawa Y, Yin C, Shigemori T, Kusunoki K, et al. Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients. Cancer Immunol Immunother. 2020;69:2533\u201346.","journal-title":"Cancer Immunol Immunother"},{"key":"16254_CR80","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3389\/fimmu.2019.02936","volume":"10","author":"SM Toor","year":"2019","unstructured":"Toor SM, Murshed K, Al-Dhaheri M, Khawar M, Abu Nada M, Elkord E. Immune checkpoints in circulating and tumor-infiltrating CD4\u2009+\u2009T cell subsets in colorectal cancer patients. Front Immunol. 2019;10:2936.","journal-title":"Front Immunol"},{"issue":"1","key":"16254_CR81","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1038\/s41598-023-30841-3","volume":"13","author":"R Dutta","year":"2023","unstructured":"Dutta R, Rathor A, Sharma HP, Pandey HC, Malik PS, Mohan A, et al. Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples. Sci Rep. 2023;13(1):3739.","journal-title":"Sci Rep"},{"key":"16254_CR82","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-020-02593-w","volume":"69","author":"R Saleh","year":"2020","unstructured":"Saleh R, Taha RZ, Toor SM, Sasidharan Nair V, Murshed K, Khawar M, et al. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer. Cancer Immunol Immunother. 2020;69:1989\u201399.","journal-title":"Cancer Immunol Immunother"},{"key":"16254_CR83","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi T. Immunologic self-tolerance maintained by CD25^+ CD^+ regulatory T cells constitutively expressing cytotoxic lymphocyte-associated antigen 4. J Exp Med. 2000;192:295.","journal-title":"J Exp Med"},{"key":"16254_CR84","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fimmu.2017.00620","volume":"8","author":"NA Johdi","year":"2017","unstructured":"Johdi NA, Ait-Tahar K, Sagap I, Jamal R. Molecular signatures of human regulatory T cells in colorectal cancer and polyps. Front Immunol. 2017;8:620.","journal-title":"Front Immunol"},{"issue":"2","key":"16254_CR85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.prp.2015.12.002","volume":"212","author":"W Hua","year":"2016","unstructured":"Hua W, Yuan A, Zheng W, Li C, Cui J, Pang Z, et al. Accumulation of FoxP3\u2009+\u2009T regulatory cells in the tumor microenvironment of human colorectal adenomas. Pathology-Research Pract. 2016;212(2):106\u201312.","journal-title":"Pathology-Research Pract"},{"issue":"4","key":"16254_CR86","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.4049\/jimmunol.1203567","volume":"191","author":"D de Kouchkovsky","year":"2013","unstructured":"de Kouchkovsky D, Esensten JH, Rosenthal WL, Morar MM, Bluestone JA, Jeker LT. microRNA-17\u201392 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitis. J Immunol. 2013;191(4):1594\u2013605.","journal-title":"J Immunol"},{"issue":"6","key":"16254_CR87","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gut.2007.123794","volume":"57","author":"S Le Gouvello","year":"2008","unstructured":"Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette M-T, Berrehar F, et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut. 2008;57(6):772\u20139.","journal-title":"Gut"},{"key":"16254_CR88","unstructured":"Li L, Han C, Chen F-X, Lu X-T, Liu J-Q, Fei S-J. Expression of CD27, CD28 and IL-17A in peripheral blood from patients with colorectal carcinoma. Eur Rev Med Pharmacol Sci. 2016;20(4):642\u201351."},{"key":"16254_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12253-014-9799-1","volume":"21","author":"G Cui","year":"2015","unstructured":"Cui G, Yang H, Zhao J, Yuan A, Florholmen J. Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence. Pathol Oncol Res. 2015;21:139\u201346.","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"16254_CR90","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3109\/00365521.2012.725089","volume":"47","author":"G Cui","year":"2012","unstructured":"Cui G, Yuan A, Goll R, Florholmen J. IL-17A in the tumor microenvironment of the human colorectal adenoma\u2013carcinoma sequence. Scand J Gastroenterol. 2012;47(11):1304\u201312.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"16254_CR91","first-page":"5516399","volume":"2021","author":"X Li","year":"2021","unstructured":"Li X, Tang J, Du H, Wang X, Wu L, Hu P, et al. Immune characters and plasticity of the sentinel lymph node in colorectal cancer patients. J Immunol Res. 2021;2021(1):5516399.","journal-title":"J Immunol Res"},{"key":"16254_CR92","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00432-010-0800-4","volume":"136","author":"H Lee","year":"2010","unstructured":"Lee H, Kim JH, Yang SY, Kong J, Oh M, Jeong DH, et al. Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. J Cancer Res Clin Oncol. 2010;136:1445\u201352.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16254_CR93","doi-asserted-by":"crossref","unstructured":"Ran X, Zhang C, Wang X, Zhao Q, Zhao Q, Yuan C, et al. Expression of CD28 in hepatocellular carcinoma and its prognostic value. Hepat Monthly. 2021;21(11):e118605.","DOI":"10.5812\/hepatmon.118605"},{"issue":"1","key":"16254_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gastro\/got041","volume":"2","author":"N Shussman","year":"2014","unstructured":"Shussman N, Wexner SD. Colorectal polyps and polyposis syndromes. Gastroenterol Rep. 2014;2(1):1\u201315.","journal-title":"Gastroenterol Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16254-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:02:01Z","timestamp":1787536921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16254"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16254-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Islamic Azad University of Medical Sciences (ethics review report number: IR.IAU.PS.REC.1400.496) approved the study. Additionally, informed and written consent was obtained from the participants in this research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1016"}}